×
Search

866-540-5505

Se Habla Espanol
Menu
Search

Our Blog

Home/Blog/Teva Agrees to $54 Million Settlement to Resolve FCA Whistleblower Suit

Teva Agrees to $54 Million Settlement to Resolve FCA Whistleblower Suit

On January 6, 2020, Teva Pharmaceuticals agreed to a $54 million settlement to resolve a False Claims Act action brought against Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., and Teva Sales and Marketing, Inc. (collectively “Teva”). The settlement resolves allegations that Teva violated the False Claims Act and the Anti-Kickback Statute by using speaker events to bribe doctors to prescribe two of its drugs, Copaxone and Azilect.

The False Claims Act (“FCA”), 31 U.S.C. §§ 3729–3733, prohibits companies from overcharging or otherwise defrauding the federal Government. Individuals who discover fraud can file a qui tam or whistleblower claim on the Government’s behalf and collect up to 30% of the proceeds of a successful lawsuit. The Anti-Kickback Statute (“AKS”), 42 U.S.C. § 1320a–7b(b), criminalizes, among other things, knowingly offering anyone a kickback (in the form bribes, rebate, or “anything of value”) induce that person to recommend the purchase of a drug covered by a federal healthcare program.

The lawsuit was brought by Plaintiff-Relators Charles Arnstein and Hossam Senousy, who were former sales representatives for Teva. The original complaint, first filed under seal on May 31, 2013, alleged that the Defendants held promotional speaker programs which served as a conduit through which doctors were bribed with speaker fees, expensive meals, and alcohol in exchange for prescribing Teva’s multiple sclerosis drug Copaxone and Parkinson’s disease treatment-drug Azilect. Physician participants of these sham speaker programs would write prescriptions for the two drugs which were then filled at pharmacies across the country. The pharmacies then submitted claims for reimbursement to various Government-funded healthcare programs. Defendants’ actions thus caused the submission of false claims to the Government via the dispensing pharmacies, making those actions violations of the FCA and AKS.

In March 2015, the court issued an order unsealing the complaint and permitting Plaintiff-Relators to prosecute claims on behalf of the United States and various states. On February 27, 2019, the Honorable Colleen McMahon, chief judge for the U.S. District Court for the Southern District of New York, denied Defendants’ motion for summary judgment. In a detailed, seventy-page opinion, Judge McMahon rejected Teva’s argument that its written compliance policies could be used to shield it from liability. “The question is whether these policies are worth the paper they are written on,” the opinion stated. Crucially, Judge McMahon found that Relators “introduced substantial evidence that Teva did, in fact, track speakers’ prescription writing,” and that “[s]ales representatives linked prescriber habits with their retention as paid speakers for Teva.”

The settlement came less than a year after Judge McMahon denied Teva’s summary judgment motion. James E. Miller, lead litigation counsel for Plaintiff-Relators, said of the settlement, “We believe that this settlement will help to ensure that when a physician chooses a prescription drug for his or her patient, that choice will be motivated solely by the best interests of the patient and not be tainted by any improper financial considerations.”

The settlement calls for Teva to pay most of the settlement amount to the federal Government, which in turn would be able to make “share payments” to Senousy and Arnstein, according to the deal. About $3.7 million will go to various other states and municipalities, according to the agreement.

The case caption for this lawsuit is U.S. ex rel. Arnstein et al. v. Teva Pharmaceuticals USA Inc. et al., case number 1:13-cv-03702, filed in the U.S. District Court for the Southern District of New York.

The legal team at Miller Shah LLP has extensive experience representing FCA and qui tam matters. If you have any questions regarding this subject or this post, please contact Bruce D. Parke (bdparke@millershah.com) or Alec Berin (ajberin@millershah.com). The Firm can also be reached toll-free at (866) 540-5505.

Share Post:
facebooktwitterLinkedin

Categories

Archives

Contact
Miller Shah LLP

While this website provides general information, it does not constitute legal advice. The best way to get guidance on your specific legal issue is to contact a lawyer. To schedule a meeting with an attorney, please call 866-540-5505 or complete the intake form to email us.
Alec J. Berin - Associate

PA Philadelphia | 866-540-5505

Alfonso Vilaboa - Of Counsel

NJ Hoboken |

Anika S. Keuning - Project Analyst

CA San Diego | 866-540-5505

Anna D’Agostino - Associate

NY New York City | 866-540-5505

Betsy Ferling-Hitriz - Legal Assistant

CT Chester | 866-540-5505

Bruce D. Parke - Partners

PA Philadelphia | 866-540-5505

Caroline Soper - Project Analyst

NY New York City | 866-540-5505

Christopher A. Miller - Associate

PA Philadelphia | 866-540-5505

Deborah C. England - Of Counsel

CA San Francisco | 866-540-5505

Edward H. Glenn - Of Counsel

NY New York City | 866-540-5505

Edward M. Fitzgerald - Staff Attorney

CA Los Angeles | 866-540-5505

Elena M. DiBattista - Legal Assistant

FL Fort Lauderdale | 866-540-5505

Elise M. Wilson - Project Analyst

NY New York City | 866-540-5505

Eric L. Young - Of Counsel

PA Philadelphia | 866-540-5505

Finn M. Mutrux - Office Staff

CA Los Angeles | 866-540-5505

Gina S. Demetriades - Office Staff

CT Chester | 866-540-5505

Heidi A. Wendel - Of Counsel

NY New York City | 866-540-5505

James C. Shah - Partners

CA Los Angeles | 866-540-5505

James E. Miller - Partners

CT Chester | 866-540-5505

Jayne A. Goldstein - Partners

FL Fort Lauderdale | 866-540-5505

Jillian M. Boyce - Office Staff

CT Chester | 866-540-5505

Jocelyn McNamara - Project Analyst

NY New York City | 866-540-5505

Johanna C. Richter - Law Clerk

PA Philadelphia | 866-540-5505

John C. Roberts - Associate

PA Philadelphia | 866-540-5505

Jonathan Dilger - Office Staff

NY New York City | 866-540-5505

Julie M. Capito - Legal Assistant

CA San Francisco | 866-540-5505

Katie Edwards - Legal Assistant

PA Philadelphia | 866-540-5505

Kolin C. Tang - Partners

CA San Diego | 866-540-5505

Laurie Rubinow - Partners

CT Chester | 866-540-5505

Madison Gregg - Associate

NY New York City | 866-540-5505

Marialisa Samo - Legal Assistant

CA San Diego | 866-540-5505

Mark Xiao - Associate

NY New York City | 866-540-5505

Natalie Finkelman Bennett - Partners

PA Philadelphia | 866-540-5505

Nathan C. Zipperian - Partners

FL Fort Lauderdale | 866-540-5505

Nicholas Day - Of Counsel

NJ Hoboken | 866-540-5505

Nicholas K. Ono - Project Analyst

NY New York City | 866-540-5505

Raffaele Scalcione - Of Counsel

IT Milan | 866-540-5505

Reilly K. Powers - Project Analyst

PA Philadelphia | 866-540-5505

Robert W. Biela - Staff Attorney

PA Philadelphia | 866-540-5505

Ronald S. Kravitz - Of Counsel

CA San Francisco | 866-540-5505

Rrita Osmani - Project Analyst

CT Chester | 866-540-5505

Shuping Li - Project Analyst

NY New York City | 866-540-5505

Stephen T. Rutkowski - Law Clerk

CT Chester | 866-540-5505

Sue Moss - Legal Assistant

PA Philadelphia | 866-540-5505

Sydney D. Finlay - Associate

CA San Diego | 866-540-5505

Tina Moukoulis - Staff Attorney

PA Philadelphia | 866-540-5505